Clinical Trials Browser

Phase 2 × Extensive Stage Small Cell Lung Cancer × Irinotecan × Clear all

NCT00057837 2023-07-05

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2 Completed

140 enrolled 8 charts

Extensive Stage Small Cell Lung Cancer

NCT00118235 2014-06-17

Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer

Phase 2 Completed

Extensive Stage Small Cell Lung Cancer